vimarsana.com

Page 5 - மஹிந்திரா மூலதனம் நிறுவனம் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Piramal Pharma acquires Hemmo Pharmaceuticals for Rs 775 Cr

Piramal Pharma acquires Hemmo Pharmaceuticals for Rs 775 Cr
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Biggest ever IPO in auto component segment! Blackstone promoted Sona Comstar files for Rs 6000 crore IPO

Highlights fund raise via fresh issue amounting to Rs 300 crore. Offer for Sale aggregating up to Rs 5700 crore. New Delhi: Sona BLW Precision Forgings Ltd, one of India’s leading automotive technology companies and a major manufacturer and supplier to global EV markets, has filed its papers with the regulator SEBI to raise and aggregate of Rs 6000 crore via Initial Public Offering.  The public issue of shares of face value of Rs 10 each, comprises a fund raise via fresh issue amounting to Rs 300 crore and an Offer for Sale aggregating up to Rs 5700 crore by selling shareholder Singapore VII Topco III Pte Ltd., an affiliate of The Blackstone Group Inc.

Blackstone promoted, Global Automotive Supplier Sona Comstar files for Rs 6000 cr IPO

Sona Comstar IPO: Blackstone-backed Sona Comstar files papers with Sebi for Rs 6,000 cr IPO

Explore Now NEW DELHI: Sona BLW Precision Forgings Ltd, an automotive technology company, filed its papers with the regulator to raise Rs 6,000 cr via Initial Public Offering (IPO). The public issue will include a fresh issue of shares amounting to Rs 300 crore and an offer for sale aggregating to up to Rs 5,700 crore by selling shareholder Singapore VII Topco III Pte Ltd, an affiliate of The Blackstone Group Inc. The portion reserved for qualified institutional buyers will be up to 75 per cent of the offer. Non-institutional investors will have up to 15 per cent of the portion reserved, while up to 10 per cent will be reserved for the retail investors.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.